Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 12/20 | 0.45 |
| ▸ | PPARG | P37231 | 11/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | CETP | P11597 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 2/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4380740 | 1.00 | PPARA (0.45) | PPARAPPARGPPARDCETPIKBKB | |
| SCHEMBL4487371 | 0.96 | PPARA (0.48) | PPARAPPARGPPARDCETPIKBKB | |
| SCHEMBL4383609 | 0.96 | PPARA (0.48) | PPARAPPARGPPARDCETPIKBKB | |
| SCHEMBL4380679 | 0.96 | PPARA (0.48) | PPARAPPARGPPARDCETPIKBKB | |
| SCHEMBL4481413 | 0.96 | PPARA (0.48) | PPARAPPARGPPARDCETPIKBKB | |
| SCHEMBL4377242 | 0.94 | PPARA (0.39) | PPARAPPARGPPARDCETPS1PR1 | |
| SCHEMBL4376906 | 0.91 | PPARG (0.38) | PPARAPPARGPPARDS1PR4S1PR1 | |
| SCHEMBL4480680 | 0.90 | PPARG (0.42) | PPARAPPARGPPARDCETPS1PR1 | |
| SCHEMBL4380140 | 0.90 | PPARG (0.42) | PPARAPPARGPPARDCETPS1PR1 | |
| SCHEMBL4391944 | 0.89 | PPARG (0.38) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789402-B1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-1789402-A1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | Sanofi-Aventis Deutschland GmbH (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006018118-A1 | 2 - {-3-`2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-02-23 | — | — | WO | disclosed |